Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcomes of Participants With Diabetes in the ISCHEMIA Trials.
Newman JD, Anthopolos R, Mancini GBJ, Bangalore S, Reynolds HR, Kunichoff DF, Senior R, Peteiro J, Bhargava B, Garg P, Escobedo J, Doerr R, Mazurek T, Gonzalez-Juanatey J, Gajos G, Briguori C, Cheng H, Vertes A, Mahajan S, Guzman LA, Keltai M, Maggioni AP, Stone GW, Berger JS, Rosenberg YD, Boden WE, Chaitman BR, Fleg JL, Hochman JS, Maron DJ. Newman JD, et al. Among authors: gajos g. Circulation. 2021 Oct 26;144(17):1380-1395. doi: 10.1161/CIRCULATIONAHA.121.054439. Epub 2021 Sep 15. Circulation. 2021. PMID: 34521217 Free PMC article.
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Relationship between polyunsaturated fatty acid composition in serum phospholipids, systemic low-grade inflammation, and glycemic control in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
Poreba M, Rostoff P, Siniarski A, Mostowik M, Golebiowska-Wiatrak R, Nessler J, Undas A, Gajos G. Poreba M, et al. Among authors: gajos g. Cardiovasc Diabetol. 2018 Feb 16;17(1):29. doi: 10.1186/s12933-018-0672-5. Cardiovasc Diabetol. 2018. PMID: 29452596 Free PMC article.
Initial Invasive or Conservative Strategy for Stable Coronary Disease.
Maron DJ, Hochman JS, Reynolds HR, Bangalore S, O'Brien SM, Boden WE, Chaitman BR, Senior R, López-Sendón J, Alexander KP, Lopes RD, Shaw LJ, Berger JS, Newman JD, Sidhu MS, Goodman SG, Ruzyllo W, Gosselin G, Maggioni AP, White HD, Bhargava B, Min JK, Mancini GBJ, Berman DS, Picard MH, Kwong RY, Ali ZA, Mark DB, Spertus JA, Krishnan MN, Elghamaz A, Moorthy N, Hueb WA, Demkow M, Mavromatis K, Bockeria O, Peteiro J, Miller TD, Szwed H, Doerr R, Keltai M, Selvanayagam JB, Steg PG, Held C, Kohsaka S, Mavromichalis S, Kirby R, Jeffries NO, Harrell FE Jr, Rockhold FW, Broderick S, Ferguson TB Jr, Williams DO, Harrington RA, Stone GW, Rosenberg Y; ISCHEMIA Research Group. Maron DJ, et al. N Engl J Med. 2020 Apr 9;382(15):1395-1407. doi: 10.1056/NEJMoa1915922. Epub 2020 Mar 30. N Engl J Med. 2020. PMID: 32227755 Free PMC article. Clinical Trial.
Optimal medical therapy in patients with stable coronary artery disease in Poland: the ISCHEMIA trial experience.
Pracoń R, Demkow M, Anthopolos R, Mazurek T, Drożdż J, Witkowski A, Gajos G, Pruszczyk P, Roik M, Łoboz-Grudzień K, Lesiak M, Reczuch K, Kalarus Z, Kryczka K, Henzel J, Kaczmarska-Dyrda E, Maksym J, Jonik S, Krekora J, Celińska-Spodar M, Jaroch J, Łanocha M, Szulik M, Szwed H, Rużyłło W. Pracoń R, et al. Among authors: gajos g. Pol Arch Intern Med. 2021 Nov 30;131(11):16100. doi: 10.20452/pamw.16100. Epub 2021 Sep 29. Pol Arch Intern Med. 2021. PMID: 34585554 Free article. Clinical Trial.
The antiischemic effects and tolerability of trimetazidine in coronary diabetic patients. A substudy from TRIMPOL-1.
Szwed H, Sadowski Z, Pachocki R, Domzał-Bocheńska M, Szymczak K, Szydłowski Z, Paradowski A, Gajos G, Kałuza G, Kulon I, Wator-Brzezińska A, Elikowski W, Kuźniak M. Szwed H, et al. Among authors: gajos g. Cardiovasc Drugs Ther. 1999 May;13(3):217-22. doi: 10.1023/a:1007744109064. Cardiovasc Drugs Ther. 1999. PMID: 10439884 Clinical Trial.
Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot).
Gajos G, Zalewski J, Rostoff P, Nessler J, Piwowarska W, Undas A. Gajos G, et al. Arterioscler Thromb Vasc Biol. 2011 Jul;31(7):1696-702. doi: 10.1161/ATVBAHA.111.228593. Epub 2011 May 26. Arterioscler Thromb Vasc Biol. 2011. PMID: 21617138 Clinical Trial.
118 results